A federal judge rejects a class action plaintiff’s parsing of a US Food and Drug Administration OTC monograph to exclude the gelcap format and a rapid release indication and to negate federal preemption of challenging a claim for a Tylenol internal analgesic formulation.
A putative class-action complaint filed against Johnson & Johnson Consumer Inc. in US District Court for Massachusetts in July...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?